Ambrx Biopharma Cayman, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Related People
Fund Service Providers
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Ambrx Biopharma Cayman, Inc.
CIK #0001836056
EDGAR Form CIK 2011 - 2026
10-K [0001836056]
10-Q [0001836056]
3 [0001836056]
4 [0001836056]
6-K [0001836056]
8-K [0001836056]
SC 13D [0001836056]
SC 13G [0001836056]
Form 13D/13G Filer Form 13D/13G Subject Filed
HOPU Reunion Co Ltd Ambrx Biopharma Inc [2023-10-10]
Paradigm Biocapital Advisors LP Ambrx Biopharma Inc [2023-09-25]
D E Shaw & Co LP Ambrx Biopharma Inc [2023-03-16]
Darwin Global Management Ltd Ambrx Biopharma Inc [2023-03-08]
Commodore Capital LP Ambrx Biopharma Inc [2023-03-03]
Venrock Healthcare Capital Partners III LP Ambrx Biopharma Inc [2023-02-27]
Darwin Global Management Ltd Ambrx Biopharma Inc [2022-12-19]
FMR LLC Ambrx Biopharma Inc [2022-02-09]
WuXi Pharmatech Healthcare Fund I LP Ambrx Biopharma Inc [2022-02-08]
Adage Capital Partners GP LLC Ambrx Biopharma Inc [2022-01-18]
View All
Form 3/4/5 Subject 2011 - 2026
Cormorant Global Healthcare Master Fund, LP
Chen Bihua
Ambrx Biopharma Cayman, Inc.
Cormorant Private Healthcare Fund III LP
Cormorant Asset Management, LP
Dalesandro Margaret
Aromando Andrew
O'Connor Daniel J.
Nelson Sonja
Darwin Global Management, Ltd.
View All
Terms | Privacy | Providers | Guide
tony@aum13f.com